N-(3-methoxyphenyl)-2,2-dimethylpropanamide, 97.0%, 25g

2-((TERT-BUTOXYCARBONYL)AMINO)-3-(P-TOLYL)PROPANOIC ACID, 95.0%, 250mg

4-Bromo-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine, 95.0%, 100mg

2-(2-(4-FLUOROBENZYL)PHENYL)ACETIC ACID, 95.0%, 250mg

Methyl 3-Iodobenzoate, 99.0%, 25g

5-Chloro-6-methyl-1-(tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 97%, 250mg

Beryllium oxide 99.98% 5 g

1-(1,1-Dimethylethyl) 4-(5-carboxy-4-methyl-2-thiazolyl)-1-piperazinecarboxylate, 100mg

2-Bromo-3-chlorophenol, 95.0%, 10g

4-Cyanophenacyl Bromide>96.0%(GC)(T)5g

Bi granules 99.999% 1-10mm 50 g

Anti-GD1b Monoclonal Antibody1vial

5-(azetidin-3-yl)-3-(furan-2-yl)-1,2,4-oxadiazole hydrochloride, 95.0%, 500mg